LASS2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-30910
Key Product Details
Species Reactivity
Human, Mouse, Rat
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Synthetic peptide derived from human LASS2 protein
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for LASS2 Antibody
Western Blot: LASS2 Antibody [NBP3-30910] -
Western Blot: LASS2 Antibody [NBP3-30910] - Western blot analysis using LAG1 longevity assurance homolog 2 at 10ug/ml on human placenta lysate 14 ug/lane. Lane A] antibody alone, Lane B] conjugate alone. Visualized using Pierce West Femto substrate system. Anti Rabbit secondary used at 1:10K dilution. Exposure for 5 minutes.Applications for LASS2 Antibody
Application
Recommended Usage
Western Blot
: 1-5 ug/ml
Application Notes
.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Ammonium sulfate precipitation
Formulation
Phosphate buffered saline
Preservative
0.08% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: LASS2
Alternate Names
ceramide synthase 2, CerS2, LAG1 homolog, ceramide synthase 2, LAG1 longevity assurance 2, LAG1 longevity assurance homolog 2, LAG1 longevity assurance homolog 2 (S. cerevisiae), S. cerevisiae) homolog 2, SP260MGC987, TMSG1, Tumor metastasis-suppressor gene 1 protein
Gene Symbol
CERS2
Additional LASS2 Products
Product Specific Notices for LASS2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...